DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Europe Market Report for Dental Growth Factor 2017 - MedCore" report to their offering.
Emdogain® is used in periodontal surgery and as a topical application for exposed root surfaces, and is indicated for the treatment of intra-bony defects due to moderate or severe periodontitis.
In the past, Emdogain® was typically only incorporated into periodontal procedure in Europe, as it is considered to be extremely effective for stimulating bone regeneration to treat certain periodontal defects. However, in May 2016 the product was cleared for a new indication of soft-tissue wound healing in oral surgical procedures and dental implantation procedures in general.
Therefore, the European market for Emdogain® will emulate growth of periodontal defects within the region but additionally incorporate a portion of growth within the DBGS market. Generally, the number of periodontal procedures per country is strongly correlated with the country's population.
However, Emdogain® has benefited from substantial marketing campaigns by Straumann since 2009 that advocated introducing the product as a resource for general practitioners to create new treatment opportunities in order to mitigate the effects of the recession.
Key Topics Covered:
1. Research Methodology
2. Disease Overview
2.1 Basic Anatomy
2.1.1 Dental Anatomy: Oral Cavity And Intraoral Landmarks
2.2 Disease Pathology And Disorders
2.2.1 General Diagnostics
2.2.2 Indication For Dental Implant
2.3 Patient Demographics
2.3.1 General Dental Statistics
2.3.2 Tooth Loss Statistics
3 Product Assessment
3.1 Product Portfolios
3.2 Regulatory Issues And Recalls
3.3 Clinical Trials
4. Country Profiles
126.96.36.199 GDP Per Capita
188.8.131.52 Dental Bone Graft Substitute Procedures Per 10,000 Inhabitants
184.108.40.206 Price Index
5. Dental Growth Factor Market
5.2 Market Analysis And Forecast
5.2.1 Emdogain® Market
5.3 Drivers And Limiters
5.3.1 Market Drivers
5.3.2 Market Limiters
5.4 Emerging Competitors And Technologies
5.4.1 Gem 21S®
5.4.3 Platelet Rich Plasma (Prp)
- Botiss Biomaterials
- Zimmer Biomet
- ACE Surgical
- Non-Profit Tissue Banks
- Tecnoss Dental
For more information about this report visit http://www.researchandmarkets.com/research/c5xnxl/europe_market